Paritosh Garg: From Replacing Platelets to Stimulating Platelet Production
Paritosh Garg, Associate Consultant at Fortis Memorial Research Institute, India, shared a post on LinkedIn about a recent article by Raoel Maan et al., published in Drugs, adding:
“Thrombocytopenia in chronic liver disease is not just a platelet-count problem.
It influences procedural planning, antiviral therapy, transfusion decisions, and thrombotic risk assessment.
This review highlights an important shift in supportive care:
From replacing platelets to stimulating platelet production.
Thrombopoietin receptor agonists opened a new therapeutic space, but the key message remains clinical judgment.
In CLD, the question is not only:
‘Can we increase the platelet count?’
It is also:
‘At what thrombotic cost, and in which patient?’
A practical reminder that supportive care in hematology is never ‘supportive only’ — it often determines whether definitive care can safely proceed.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments